Remedy Meds To Acquire Thirty Madison, Expanding Telehealth Capabilities

Remedy Meds, LLC, a consumer virtual-care and pharmacy platform, announced that it has entered into a definitive agreement to acquire Thirty Madison, Inc. (Thirty Madison). The transaction creates a larger, multi-brand platform across women's, men's, and metabolic health, according to the announcement. The transaction, which is valued just above $500 million, will be funded through an all-stock deal. Closing is expected in the fourth quarter of 2025, subject to customary closing conditions and regulatory review.

The strategic rationale for the acquisition, according to the announcement, is:

Scaled, multi-brand platform: Combines Remedy Meds (weight loss . . .